Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Seung Hwan Han,1 Gyu Chul Oh,2 Hyuck Moon Kwon,3 Chang Gyu Park,4 In Jai Kim,5 Gyo-Seung Hwang,6 Byung Su Yoo,7 Seong Hoon Park,8 Kwang Je Lee,9 Hyo-soo Kim21Division of Cardiology, Department of Internal Medicine, Gachon University College of Medicine, Gil Hospital, Incheon, Republic of Korea; 2Div...

Full description

Bibliographic Details
Main Authors: Han SH, Oh GC, Kwon HM, Park CG, Kim IJ, Hwang GS, Yoo BS, Park SH, Lee KJ, Kim HS
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Drug Design, Development and Therapy
Subjects:
irbesartan
generic medicine
hypertension
anti-hypertensive
Online Access:https://www.dovepress.com/comparison-of-efficacy-and-safety-between-two-different-irbesartan-gen-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/comparison-of-efficacy-and-safety-between-two-different-irbesartan-gen-peer-reviewed-article-DDDT

Similar Items